-
China International Import Expo opens listening mode, 'all students' look forward to the prospects of the Chinese market
He Siwen said, "On the platform of the CIIE, we have launched a listening mode, showcasing various products at the CIIE, collecting consumer needs and feedback, and helping to determine the products ...- fwhss200469
- 2024-11-8 12:44
- 支持
- 反对
- 回复
- 收藏
-
Yizi International further expands its business in China and significantly increases its equity investment in Enxi Village
-By significantly increasing investment in China, we aim to strengthen our leadership position in the baking food category -Further meet the demand of young consumers in China's high-end market for f ... -
Yizi International further expands its business in China and significantly increases its equity investment in Enxi Village
On September 21st, Mondelez International announced that the company has signed an agreement with Enxi Village (Shanghai) Industrial Co., Ltd., a leading Chinese bakery manufacturer, to significantly ... -
Yizi International expands its business in China and adds equity investment in Enxi Village
Yizi International announced on September 21st that the company has signed an agreement with Enxi Village (Shanghai) Industrial Co., Ltd. to significantly increase its equity investment in Enxi Villa ... -
"Weight loss pills" are sold in limited quantities in China? Novo Nordisk's latest response
On June 27th, it was reported in the market that the "weight loss miracle drug" Wegovy (Chinese product name: Nuoheying) will be sold in limited quantities in China. On June 28th, relevant personnel ... -
How effective is the drug supply process initiated by Novo Nordisk for the approved slimming version of Smegglutide in China?
Novo Nordisk Star Product Smegglutide has been approved in China for long-term weight loss management. On June 25th, Novo Nordisk announced that the National Medical Products Administration (NMPA) ha ... -
Novo Nordisk's new weight loss oral medication is applying for clinical efficacy or surpassing smeglutide in China
On April 10th, the official website of the Drug Evaluation Center (CDE) of the National Medical Products Administration of China announced that the clinical trial application for the Class 1 new oral ...- Ty奇葩罗牛山831
- 2024-4-11 19:03
- 支持
- 反对
- 回复
- 收藏
-
The big news of "weight loss miracle drug"! Oral Smegglutide Approved for Market in China
According to the information released by the State Drug Administration on January 26, Smeglutide tablets under Novo Nordisk (China) Pharmaceutical Co., Ltd. have been approved for marketing to treat ... -
Gilead Science's second HIV pre exposure prophylactic drug has been approved in China, and the awareness rate of PrEP in China is still relatively low
AIDS is a serious disease caused by human immunodeficiency virus (HIV) infection. With the establishment of cocktail therapy and the gradual optimization of treatment plan, AIDS has become a controll ... -
Sanofi lipid-lowering drug Zhilida approved in China
On December 27th, Sanofi announced on its official WeChat account that its rosuvastatin ezetimibe tablets (I) have been approved by the National Medical Products Administration of China for the treat ... -
Left hand cooperation and right hand promotion of research and development: Sanofi's layout in China enters a new stage
On Wednesday of this week, the National Medical Insurance Administration announced the results of this year's medical insurance negotiations. Compared with the main theme of "soul bargaining" in prev ... -
Helping customers in China to reduce costs and increase efficiency in the field of mature process chip manufacturing
From November 5th to 10th, the 6th CIIE was held in Shanghai. As an exhibitor, the global lithography giant ASML (hereinafter referred to as "ASML") has received increasing attention in the past two ... -
Survey: Nearly half of large multinational corporations in China are concerned about China's risks and considering relocating production
In an economic briefing released on Monday (November 6th), the European Central Bank said that over 40% of many multinational companies surveyed by the European Central Bank are expected to relocate ... -
【 Direct Attack on the China International Expo 】 Experience the "Spillover Effect" of China International Expo, Geely's Second Exhibition Expands Its Moments in China
Xinhua Finance and Economics, Shanghai, November 9 (Reporter Du Kang) - Geely Science, a leading global biopharmaceutical company, has embarked on its second "journey to enter the international marke ... -
Opportunities in China | FedEx: Strengthening its presence in China, China's air cargo market still has growth potential
FedEx is full of confidence in the Chinese market and will support China's sustainable development with a long-term perspective and strategy. We will continue to enhance our layout in the Chinese mar ... -
AstraZeneca Wang Lei: Continue to increase investment in research and development and medical innovation in China
Wang Lei, Global Executive Vice President and President of International Business and China at AstraZeneca, stated that over the past five years, relying on the advantages of China's large market, ... -
WPP fires employees detained in China and initiates an investigation into bribery allegations
WPP stated that the company has dismissed executives currently detained in China on suspicion of bribery and is conducting an internal investigation into the matter. The Shanghai Police Economic Crim ...